All posts by Arthritis Foundation

What’s Important to Juvenile Idiopathic Arthritis (JIA) Families: the JIA Voice of the Patient Report

Arthritis patients have spoken: “We want safer, more effective, easier-to-use and less-painful-to-administer treatments that are less likely to cause potential long-term side effects. We need solutions to the challenges of dealing with comorbidities and multiple treatment changes.” Continue reading What’s Important to Juvenile Idiopathic Arthritis (JIA) Families: the JIA Voice of the Patient Report

Researchers on the Path to a Cure – Spotlight on Dr. Xiaojuan Li

Last year we introduced you to Dr. Xiaojuan Li and her Osteoarthritis (OA) Center of Excellence demonstration research project. The project, “Multi-site Multi-Vendor Cross-validation of Cartilage T1rho and T2 imaging”, was completed by investigators from four sites: the Cleveland Clinic Foundation (CCF) in Ohio; the University of California, San Francisco; the University of Kentucky; and the Montefiore Hospital and Albert Einstein College of Medicine in New York. They worked to quantify biomarker assessments in cartilage images obtained through magnetic resonance imaging (MRI). Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Xiaojuan Li

New “Lesson Plans” Designed to Improve Patient Outcomes

The Arthritis Foundation has just launched new “lesson plans” to help improve patient outcomes. The initiative was based on patient and provider surveys and focus groups, which showed that patients want information and support to improve their physical health, emotional health and experience of care. Continue reading New “Lesson Plans” Designed to Improve Patient Outcomes

Protect Yourself From the Measles

Since January 2019, the Centers for Disease Control and Prevention (CDC) has reported nearly 850 cases of measles in 23 states – the largest number of measles infections since 1994. Most people who have been infected were unvaccinated. Although measles was declared eliminated in the United States in 2000, it has made a recent comeback, thanks to travelers bringing the virus in from other countries and a growing population of unvaccinated Americans. How worried should you be? Continue reading Protect Yourself From the Measles

Our Rheumatology Learning Health System Is Starting to Attract Attention!

A big part of our Collaborating With Patients for Better Health scientific initiative has been development of the Rheumatology Learning Health System (RLHS) in collaboration with some of our major partners. The goal of RLHS is to improve quality of care for pediatric and adult arthritis patients.
Continue reading Our Rheumatology Learning Health System Is Starting to Attract Attention!

FDA Approves New Bone-Building Drug for Osteoporosis

The Food and Drug Administration (FDA) recently approved romosozumab (Evenity), a new drug for osteoporosis. Unlike osteoporosis medicines called bisphosphonates, romosozumab doesn’t just stop bone loss; it also helps build new bone. It’s approved for postmenopausal women who have fractures, are at very high risk for fractures or haven’t responded to other treatments. The drug comes with an FDA warning for an increased risk of heart attack, stroke and cardiovascular death. Continue reading FDA Approves New Bone-Building Drug for Osteoporosis

Revealing the Truth About Arthritis During Arthritis Awareness Month

“I don’t know many people with arthritis.”

 “It’s a disease that affects older people.”

 “Anyone can live with a little joint pain.”

 “Are you sure what you’re experiencing isn’t just in your head?”

From coast to coast, this is what we hear about arthritis every day. Although more Americans are living with arthritis than those with breast cancer, diabetes, Alzheimer’s and autism combined, most people know very little about this debilitating disease. In fact, only 7% of Americans realize it’s the No. 1 cause of long-term disability in the United States. Continue reading Revealing the Truth About Arthritis During Arthritis Awareness Month